ADD TO CART

Retatrutide

Retatrutide is a research compound supplied as a lyophilised (freeze-dried) vial for laboratory research and educational use only. The product image shows a 40mg vial at 99.6% purity.


Reported areas of research interest: Retatrutide is described as a triple-agonist research compound active across the GLP-1, GIP and glucagon receptor pathways. In preclinical (non-human) studies, compounds in this class have been investigated for reported roles in metabolic, glucose-regulation and body-weight research models. These represent areas of ongoing scientific investigation only.


DRAFT LISTING: please verify your own label, COA, strength, storage instructions and fulfilment details before publishing. Bacteriostatic water and accessories are sold separately. For research purposes only — not for human or animal consumption, or for clinical, diagnostic or therapeutic use.

£40.00

Size

  • SPECIFICATIONS

    Type: Triple-agonist research compound (GLP-1 / GIP / glucagon pathways)

    Size (per image): 40mg

    Purity (per image): 99.6%

    Reported half-life: ~6 days (per source background article)

    Form: Lyophilised (freeze-dried) vial

    Note: Draft listing - confirm your own purity, testing and storage data before going live.

  • HOW TO USE

    Storage: Confirm storage instructions against your own supplier guidance before publishing. General research peptide guidance: store lyophilised material at -20°C, away from UV light; once reconstituted, store at 2°C–6°C, away from UV light.

    Reconstitution: Bacteriostatic water and accessories are sold separately.

    For research purposes only. Not for human or animal consumption, or for clinical, diagnostic or therapeutic use.

BESTSELLERS

You may also like